These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 19639112)

  • 1. Topical photodynamic therapy with porphyrin precursors--assessment of treatment-associated pain in a retrospective study.
    Steinbauer JM; Schreml S; Babilas P; Zeman F; Karrer S; Landthaler M; Szeimies RM
    Photochem Photobiol Sci; 2009 Aug; 8(8):1111-6. PubMed ID: 19639112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methyl-aminolevulinate photodynamic therapy for the treatment of actinic keratoses and non-melanoma skin cancers: a retrospective analysis of response in 462 patients.
    Fai D; Arpaia N; Romano I; Vestita M; Cassano N; Vena GA
    G Ital Dermatol Venereol; 2009 Jun; 144(3):281-5. PubMed ID: 19528909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Real-life practice study of the clinical outcome and cost-effectiveness of photodynamic therapy using methyl aminolevulinate (MAL-PDT) in the management of actinic keratosis and basal cell carcinoma.
    Annemans L; Caekelbergh K; Roelandts R; Boonen H; Leys C; Nikkels AF; van Den Haute V; van Quickenborne L; Verhaeghe E; Leroy B
    Eur J Dermatol; 2008; 18(5):539-46. PubMed ID: 18693157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pain during topical photodynamic therapy - comparing methyl aminolevulinate (Metvix
    Yazdanyar S; Zarchi K; Jemec GBE
    Photodiagnosis Photodyn Ther; 2017 Dec; 20():6-9. PubMed ID: 28780136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The France-PDT study: a national prospective observational cohort survey on the use of methyl-aminolevulinate photodynamic therapy in France, with up to 6-month follow-up.
    Farhi D; Bedane C; Savary J; Basset-Seguin N
    Eur J Dermatol; 2013; 23(1):68-76. PubMed ID: 23400280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Photodynamic therapy induces less pain in patients treated with methyl aminolevulinate compared to aminolevulinic acid.
    Kasche A; Luderschmidt S; Ring J; Hein R
    J Drugs Dermatol; 2006 Apr; 5(4):353-6. PubMed ID: 16673803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is the pain of topical photodynamic therapy with methyl aminolevulinate any different from that with 5-aminolaevulinic acid?
    Ibbotson SH; Valentine R; Hearn R
    Photodermatol Photoimmunol Photomed; 2012 Oct; 28(5):272-3. PubMed ID: 22971196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Daylight methyl-aminolevulinate photodynamic therapy versus ingenol mebutate for the treatment of actinic keratoses: an intraindividual comparative analysis.
    Genovese G; Fai D; Fai C; Mavilia L; Mercuri SR
    Dermatol Ther; 2016 May; 29(3):191-6. PubMed ID: 26799440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Photodynamic therapy with BF-200 ALA for the treatment of actinic keratosis: results of a multicentre, randomized, observer-blind phase III study in comparison with a registered methyl-5-aminolaevulinate cream and placebo.
    Dirschka T; Radny P; Dominicus R; Mensing H; Brüning H; Jenne L; Karl L; Sebastian M; Oster-Schmidt C; Klövekorn W; Reinhold U; Tanner M; Gröne D; Deichmann M; Simon M; Hübinger F; Hofbauer G; Krähn-Senftleben G; Borrosch F; Reich K; Berking C; Wolf P; Lehmann P; Moers-Carpi M; Hönigsmann H; Wernicke-Panten K; Helwig C; Foguet M; Schmitz B; Lübbert H; Szeimies RM;
    Br J Dermatol; 2012 Jan; 166(1):137-46. PubMed ID: 21910711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors predicting pain and effect of oral analgesia in topical photodynamic therapy.
    Hambly RA; Mansoor N; Quinlan C; Shah Z; Lenane P; Ralph N; Moloney FJ
    Photodermatol Photoimmunol Photomed; 2017 May; 33(3):176-179. PubMed ID: 28196277
    [No Abstract]   [Full Text] [Related]  

  • 11. Daylight photodynamic therapy with methyl aminolevulinate cream is effective and nearly painless in treating actinic keratoses: a randomised, investigator-blinded, controlled, phase III study throughout Europe.
    Lacour JP; Ulrich C; Gilaberte Y; Von Felbert V; Basset-Seguin N; Dreno B; Girard C; Redondo P; Serra-Guillen C; Synnerstad I; Tarstedt M; Tsianakas A; Venema AW; Kelleners-Smeets N; Adamski H; Perez-Garcia B; Gerritsen MJ; Leclerc S; Kerrouche N; Szeimies RM
    J Eur Acad Dermatol Venereol; 2015 Dec; 29(12):2342-8. PubMed ID: 26435363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of acute postoperative hypertension after topical photodynamic therapy for non-melanoma skin cancer.
    Borroni RG; Carugno A; Rivetti N; Arbustini E; Brazzelli V
    Photodermatol Photoimmunol Photomed; 2013 Apr; 29(2):73-7. PubMed ID: 23458390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment with 5-aminolaevulinic acid methylester is less painful than treatment with 5-aminolaevulinic acid nanoemulsion in topical photodynamic therapy for actinic keratosis.
    Gholam P; Weberschock T; Denk K; Enk A
    Dermatology; 2011; 222(4):358-62. PubMed ID: 21757880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Similar effectiveness of methyl aminolevulinate and 5-aminolevulinate in topical photodynamic therapy for nodular basal cell carcinoma.
    Kuijpers DI; Thissen MR; Thissen CA; Neumann MH
    J Drugs Dermatol; 2006; 5(7):642-5. PubMed ID: 16865869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current methods for photodynamic therapy in the US: comparison of MAL/PDT and ALA/PDT.
    Lee PK; Kloser A
    J Drugs Dermatol; 2013 Aug; 12(8):925-30. PubMed ID: 23986167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Daylight photodynamic therapy with methyl aminolevulinate cream as a convenient, similarly effective, nearly painless alternative to conventional photodynamic therapy in actinic keratosis treatment: a randomized controlled trial.
    Rubel DM; Spelman L; Murrell DF; See JA; Hewitt D; Foley P; Bosc C; Kerob D; Kerrouche N; Wulf HC; Shumack S
    Br J Dermatol; 2014 Nov; 171(5):1164-71. PubMed ID: 24861492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Photodynamic therapy with methyl aminolevulinate for primary nodular basal cell carcinoma: results of two randomized studies.
    Foley P; Freeman M; Menter A; Siller G; El-Azhary RA; Gebauer K; Lowe NJ; Jarratt MT; Murrell DF; Rich P; Pariser DM; Oseroff AR; Barnetson R; Anderson C; Kossard S; Gibson LE; Tope WD
    Int J Dermatol; 2009 Nov; 48(11):1236-45. PubMed ID: 20064185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Photodynamic therapy with the use of superluminescent diodes (sLED) in the treatment of actinic keratosis.
    Bartosińska J; Wolska-Gawron K; Gerkowicz A; Niewiedzioł M; Michalska-Jakubus M; Komza M; Klepaczewski T; Kwaśny M; Krasowska D
    Photodiagnosis Photodyn Ther; 2018 Jun; 22():187-190. PubMed ID: 29684690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conventional vs. daylight methyl aminolevulinate photodynamic therapy for actinic keratosis of the face and scalp: an intra-patient, prospective, comparison study in Italy.
    Fargnoli MC; Piccioni A; Neri L; Tambone S; Pellegrini C; Peris K
    J Eur Acad Dermatol Venereol; 2015 Oct; 29(10):1926-32. PubMed ID: 25809617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized, double-blind, prospective study to compare topical 5-aminolaevulinic acid methylester with topical 5-aminolaevulinic acid photodynamic therapy for extensive scalp actinic keratosis.
    Moloney FJ; Collins P
    Br J Dermatol; 2007 Jul; 157(1):87-91. PubMed ID: 17501954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.